title: Optical coherence tomographic angiography of choroidal neovascularization associated with central serous chorioretinopathy.
authors.affiliation: Casey Eye Institute, Oregon Health and Science University, Portland.
authors.forename: Scott M
authors.initials: SM
authors.lastname: McClintic
authors.affiliation: Casey Eye Institute, Oregon Health and Science University, Portland.
authors.forename: Yali
authors.initials: Y
authors.lastname: Jia
authors.affiliation: Casey Eye Institute, Oregon Health and Science University, Portland.
authors.forename: David
authors.initials: D
authors.lastname: Huang
authors.affiliation: Casey Eye Institute, Oregon Health and Science University, Portland.
authors.forename: Steven T
authors.initials: ST
authors.lastname: Bailey
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000068258:Bevacizumab / Q000627:therapeutic use; D056833:Central Serous Chorioretinopathy / Q000150:complications*; D020256:Choroidal Neovascularization / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D012171:Retinal Vessels / Q000473:pathology; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab